SPRO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Spero Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.83 USD -2.41% Market Closed

Market Cap: $163.8m

	Spero Therapeutics Inc NASDAQ:SPRO	US
S	Steel Dynamics Inc XBER:SD5	US
	Morgan Stanley NYSE:MS	US
	Kadokawa Corp TSE:9468	JP
T	Tapestry Inc DUS:COY	US
F	FedEx Corp BMV:FDX	US
	Dynamatic Technologies Ltd NSE:DYNAMATECH	IN
	En Japan Inc TSE:4849	JP
	Pyrum Innovations AG F:PYR	DE
	Nov Inc NYSE:NOV	US
	Lufax Holding Ltd NYSE:LU	CN
	DBV Technologies SA NASDAQ:DBVT	FR
	Equinox Gold Corp TSX:EQX	CA

Profitability Summary

Spero Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

11%

Negative 3Y Average Operating Margin

-45%

Operating Margin is Increasing

-56% > 11%

Healthy Net Margin

13%

Negative 3Y Average Net Margin

-42%

Net Margin is Increasing

-50% > 13%

Negative Free Cash Flow Margin

-19%

Negative 3Y Average Free Cash Flow Margin

-26%

Declining Free Cash Flow Margin

14% > -19%

Positive ROE

16%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-43%

ROIC is Increasing

-172% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.